These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 9844784)
21. Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis. Wu JJ; Rowan CG; Bebchuk JD; Anthony MS J Am Acad Dermatol; 2015 May; 72(5):917-9. PubMed ID: 25748312 [No Abstract] [Full Text] [Related]
22. Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancer. Masson D; Denis MG; Denis M; Blanchard D; Loirat MJ; Cassagnau E; Lustenberger P Br J Cancer; 1999 Aug; 80(12):1995-2000. PubMed ID: 10471052 [TBL] [Abstract][Full Text] [Related]
23. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. Kane D; Roth J; Frosch M; Vogl T; Bresnihan B; FitzGerald O Arthritis Rheum; 2003 Jun; 48(6):1676-85. PubMed ID: 12794836 [TBL] [Abstract][Full Text] [Related]
24. Noninvasive diagnosis of bladder carcinoma by enzyme-linked immunosorbent assay detection of CD44 isoforms in exfoliated urothelia. Woodman AC; Goodison S; Drake M; Noble J; Tarin D Clin Cancer Res; 2000 Jun; 6(6):2381-92. PubMed ID: 10873090 [TBL] [Abstract][Full Text] [Related]
25. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer. Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Cosio S; Prontera C; Bianchi R; Genazzani AR Anticancer Res; 1997; 17(6D):4463-6. PubMed ID: 9494551 [TBL] [Abstract][Full Text] [Related]
26. Serum level of receptor activator of nuclear factor kappa-B ligand in patients with psoriasis. Amin TE; ElFar NN; Ghaly NR; Hekal MM; Hassan AM; Elsaadany HM Int J Dermatol; 2016 May; 55(5):e227-33. PubMed ID: 26712216 [TBL] [Abstract][Full Text] [Related]
27. Elevated C-Reactive Protein Level Predicts Earlier Treatment with Tumor Necrosis Factor-Alpha Inhibitors in Psoriatic Arthritis. Ofer-Shiber S; Molad Y Isr Med Assoc J; 2016 May; 18(5):279-82. PubMed ID: 27430084 [TBL] [Abstract][Full Text] [Related]
28. Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis. Cauza E; Cauza K; Hanusch-Enserer U; Etemad M; Dunky A; Kostner K Wien Klin Wochenschr; 2002 Dec; 114(23-24):1004-7. PubMed ID: 12635469 [TBL] [Abstract][Full Text] [Related]
29. Anti-citrulline antibodies in psoriatic patients with and without arthritis. Parodi A; Drosera M; Seriolo B; Barbieri L; Rebora A Acta Derm Venereol; 2005; 85(3):253-4. PubMed ID: 16040413 [No Abstract] [Full Text] [Related]
31. Human mast cells express the hyaluronic-acid-binding isoform of CD44 and adhere to hyaluronic acid. Fukui M; Whittlesey K; Metcalfe DD; Dastych J Clin Immunol; 2000 Mar; 94(3):173-8. PubMed ID: 10692236 [TBL] [Abstract][Full Text] [Related]
32. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis. Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600 [TBL] [Abstract][Full Text] [Related]
33. [Clinical picture of arthritis caused by psoriasis]. van Romunde LK Acta Rhumatol; 1979; 3(3):207-11. PubMed ID: 11496642 [No Abstract] [Full Text] [Related]
34. Pre-transplant plasma and cellular levels of CD44 correlate with acute renal allograft rejection. Rouschop KM; Roelofs JJ; Rowshani AT; Leemans JC; van der Poll T; Ten Berge IJ; Weening JJ; Florquin S Nephrol Dial Transplant; 2005 Oct; 20(10):2248-54. PubMed ID: 16166750 [TBL] [Abstract][Full Text] [Related]
35. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients. Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225 [TBL] [Abstract][Full Text] [Related]
36. Antibodies to streptococcal cell wall in psoriatic arthritis and cutaneous psoriasis. Rantakokko K; Rimpiläinen M; Uksila J; Jansèn C; Luukkainen R; Toivanen P Clin Exp Rheumatol; 1997; 15(4):399-404. PubMed ID: 9272301 [TBL] [Abstract][Full Text] [Related]
37. Altered monocyte CD44 expression in peripheral arterial disease is corrected by fish oil supplementation. Madden J; Shearman CP; Dunn RL; Dastur ND; Tan RM; Nash GB; Rainger GE; Brunner A; Calder PC; Grimble RF Nutr Metab Cardiovasc Dis; 2009 May; 19(4):247-52. PubMed ID: 18804988 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma. Van Hal NL; Van Dongen GA; Ten Brink CB; Heider KH; Rech-Weichselbraun I; Snow GB; Brakenhoff RH Clin Cancer Res; 1999 Nov; 5(11):3534-41. PubMed ID: 10589769 [TBL] [Abstract][Full Text] [Related]
39. Serum levels of soluble CD44 in primary Sjögren's syndrome. Levesque MC; Mackin DA; Fleming JA; St Clair EW J Rheumatol; 2000 Jun; 27(6):1444-9. PubMed ID: 10852268 [TBL] [Abstract][Full Text] [Related]
40. Sustained response to long-term biologics and switching in psoriatic arthritis: results from real life experience. Coates LC; Cawkwell LS; Ng NW; Bennett AN; Bryer DJ; Fraser AD; Emery P; Marzo-Ortega H Ann Rheum Dis; 2008 May; 67(5):717-9. PubMed ID: 18055476 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]